INBORN DISORDERS OF SPHINGOLIPID METABOLISM

By W. NAURL

CONTENTS CHAPTER MUCOLIPIDOSIS DISEASE IN THE UNITED ARAB EMIRATES CHAPTER SIALIDOSIS AND GALACTOSIALIDOSIS: MOLECULAR MECHANISM AND THERAPEUTIC EFFECT MUCOPOLYSACCHARIDOSIS TYPE III MUCOPOLYSACCHARIDOSIS TYPE VII/SLY DISEASE: MOLECULAR MECHANISM AND THERAPEUTIC EFFECT GM2 GANGLIOSIDOSIS /TAY SACHS DISEASE: MOLECULAR MECHANISM AND THERAPEUTIC EFFECT GM2 GANGLIOSIDOSES TYPE II/SANDHOFF DISEASE (SD): DIAGNOSIS AND THERAPEUTIC EFFECT METACHROMATIC LEUKODYSTROPHY: MOLECULAR MECHANISM AND THERAPEUTIC EFFECT PARKINSON’S DISEASE ASSOCIATION WITH GAUCHER DISEASE AND THERAPEUTIC EFFECT PHENYLKETONURIA: DIAGNOSIS AND THERAPEUTICAL OPTIONS CURRENT TRENDS IN CANAVAN DISEASE RESEARCH AND THERAPEUTIC EFFECT